News
Marc Princen appointed new Global CEO for Mundipharma
Mundipharma announced that Marc Princen has joined the Mundipharma network of independently associated companies as the Global Chief Executive Officer,effective June 1, 2020. In...
News
Boehringer Ingelheim Appoints Jean-Michel Boers as U.S. Country Managing Director, President & CEO
Boehringer Ingelheim announced that Dr. Wolfgang Baiker, U.S. Country Managing Director, President and CEO, will retire after 31 years of committed service to the...
News
Biorelate Ltd offers free access to AI drug discovery tool
The company is granting researchers free use of cloud-based Galactic AI technology while the COVID-19 pandemic continues to impact labs worldwide.
Biorelate has announced it...
Clinical Trials
Imperial College London to begin human testing of new Covid-19 vaccine
The study will be the first time Imperial’s vaccine has been trialled in humans and will assess whether it is well-tolerated and produces an...
Drug Research
Cobra signs supply agreement with AstraZeneca for manufacture of COVID-19 vaccine candidate
Cobra Biologics, part of the Cognate BioServices family, an international CDMO for biologics and pharmaceuticals, announced it has signed a supply agreement with AstraZeneca...
Drug Research
Neurocrine and Takeda Ink $2 Billion-Plus Neuroscience Development Deal
San Diego-based Neurocrine Biosciences is partnering with Japan’s Takeda Pharmaceutical to develop and commercialize molecules in Takeda’s early-to-mid-stage psychiatry pipeline. Takeda granted an exclusive...
Press Releases
Jazz Pharma Gets Approval for Zepzelca in the U.S. for Aggressive Lung Cancer
The U.S. FDA approved Jazz Pharmaceuticals and its partner PharmaMar’s Zepzelca (lurbinectedin) for adults with metastatic small cell lung cancer (SCLC) whose disease has...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read